{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:48:40Z","timestamp":1792612120650,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s13555-022-00826-7","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T08:03:15Z","timestamp":1665734595000},"page":"2669-2678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["New Developing Treatments for Molluscum Contagiosum"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-2060","authenticated-orcid":false,"given":"Francesco","family":"Lacarrubba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-3939","authenticated-orcid":false,"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Calogero","family":"Trecarichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Quattrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Monfrecola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-6099","authenticated-orcid":false,"given":"Anna Elisa","family":"Verz\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"issue":"10","key":"826_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1473-3099(13)70109-9","volume":"13","author":"X Chen","year":"2013","unstructured":"Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis. 2013;13(10):877\u201388.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"826_CR2","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.36849\/JDD.6383","volume":"20","author":"L Eichenfield","year":"2021","unstructured":"Eichenfield L, Hebert A, Mancini A, Rosen T, Weiss J. Therapeutic approaches and special considerations for treating molluscum contagiosum. J Drugs Dermatol. 2021;20(11):1185\u201390.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"826_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/fampra\/cmt075","volume":"31","author":"JR Olsen","year":"2014","unstructured":"Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014;31(2):130\u20136.","journal-title":"Fam Pract"},{"key":"826_CR4","first-page":"1633","volume-title":"Forfar and Arneil\u2019s textbook of pediatrics","author":"M Rogers","year":"1998","unstructured":"Rogers M, Barnetson RSC, et al. Diseases of the skin. In: Campbell AGM, McIntosh N, et al., editors. Forfar and Arneil\u2019s textbook of pediatrics. 5th ed. New York: Churchill Livingstone; 1998. p. 1633\u20135.","edition":"5"},{"key":"826_CR5","first-page":"89","volume-title":"Genus molluscipoxvirus. Poxviruses Birkh\u00e4user advances in infectious diseases","author":"J Bugert","year":"2007","unstructured":"Bugert J. Genus molluscipoxvirus. Poxviruses Birkh\u00e4user advances in infectious diseases. Basel: Birkhauser; 2007. p. 89\u2013112."},{"issue":"6","key":"826_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1525-1470.2006.00313.x","volume":"23","author":"D Hanna","year":"2006","unstructured":"Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23(6):574\u20139.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"826_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1872213X11666170518114456","volume":"11","author":"AKC Leung","year":"2017","unstructured":"Leung AKC, Barankin B, Hon KLE. Molluscum contagiosum: an update. Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):22\u201331.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/ced.12444","volume":"40","author":"SH Ku","year":"2015","unstructured":"Ku SH, Cho EB, Park EJ, Kim KH, Kim KJ. Dermoscopic features of molluscum contagiosum based on white structures and their correlation with histopathological findings. Clin Exp Dermatol. 2015;40:208\u201310.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"826_CR9","first-page":"521","volume":"150","author":"F Lacarrubba","year":"2015","unstructured":"Lacarrubba F, Verz\u00ec AE, Dinotta F, Scavo S, Micali G. Dermatoscopy in inflammatory and infectious skin disorders. G Ital Dermatol Venereol. 2015;150(5):521\u201331.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"826_CR10","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1111\/ajd.12511","volume":"58","author":"F Lacarrubba","year":"2017","unstructured":"Lacarrubba F, Verzi AE, Ardigo M, Micali G. Handheld reflectance confocal microscopy for the diagnosis of molluscum contagiosum: histopathology and dermoscopy correlation. Australas J Dermatol. 2017;58(3):e123\u20135.","journal-title":"Australas J Dermatol"},{"issue":"1","key":"826_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/archderm.144.1.134","volume":"144","author":"A Scope","year":"2008","unstructured":"Scope A, Benvenuto-Andrade C, Gill M, Ardigo M, Gonzalez S, Marghoob AA. Reflectance confocal microscopy of molluscum contagiosum. Arch Dermatol. 2008;144(1):134.","journal-title":"Arch Dermatol"},{"issue":"12","key":"826_CR12","doi-asserted-by":"publisher","first-page":"e934","DOI":"10.1111\/jdv.17594","volume":"35","author":"AE Verz\u00ec","year":"2021","unstructured":"Verz\u00ec AE, Micali G, Lacarrubba F. Line-field confocal optical coherence tomography in molluscum contagiosum: a case series. J Eur Acad Dermatol Venereol. 2021;35(12):e934\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"826_CR13","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/cup.14106","volume":"48","author":"G Broggi","year":"2021","unstructured":"Broggi G, Verz\u00ec AE, Micali G, Caltabiano R, Lacarrubba F. Horizontal histopathology correlates with in vivo reflectance confocal microscopy features of molluscum contagiosum: a case series. J Cutan Pathol. 2021;48(11):1430\u20131.","journal-title":"J Cutan Pathol"},{"issue":"6","key":"826_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.clindermatol.2021.07.002","volume":"39","author":"S Phan","year":"2021","unstructured":"Phan S, Wyant C, Huynh C, Joaquin C, Hassan O. Efficacy of topical treatments for molluscum contagiosum in randomized controlled trials. Clin Dermatol. 2021;39(6):1005\u201313.","journal-title":"Clin Dermatol"},{"issue":"3","key":"826_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/pde.12504","volume":"32","author":"H Basdag","year":"2015","unstructured":"Basdag H, Rainer BM, Cohen BA. Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatr Dermatol. 2015;32(3):353\u20137.","journal-title":"Pediatr Dermatol"},{"key":"826_CR16","first-page":"CD004767","volume":"5","author":"JC van der Wouden","year":"2017","unstructured":"van der Wouden JC, Menke J, Gajadin S, et al. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5:CD004767.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"826_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1473-3099(14)71053-9","volume":"15","author":"JR Olsen","year":"2015","unstructured":"Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infect Dis. 2015;15(2):190\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"826_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1473-3099(14)71061-8","volume":"15","author":"AK Leung","year":"2015","unstructured":"Leung AK. The natural history of molluscum contagiosum in children. Lancet Infect Dis. 2015;15(2):136\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"826_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2165\/00148581-200305080-00001","volume":"5","author":"N Silverberg","year":"2003","unstructured":"Silverberg N. Pediatric molluscum contagiosum: optimal treatment strategies. Paediatr Drugs. 2003;5(8):505\u201312.","journal-title":"Paediatr Drugs"},{"key":"826_CR20","first-page":"460","volume-title":"Treatment of skin disease: comprehensive therapeutic strategies","author":"A Javed","year":"2014","unstructured":"Javed A, Coulson I. Molluscum contagiosum. In: Lebwohl MG, Berth-Jones J, Heymann WR, Coulson I, editors. Treatment of skin disease: comprehensive therapeutic strategies. 4th ed. Philadelphia: Elsevier-Saunders USA; 2014. p. 460\u20133.","edition":"4"},{"issue":"5","key":"826_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ad.2018.01.007","volume":"109","author":"P Gerlero","year":"2018","unstructured":"Gerlero P, Hernandez-Martin A. Update on the treatment of molluscum contagiosum in children. Actas Dermosifiliogr. 2018;109(5):408\u201315.","journal-title":"Actas Dermosifiliogr"},{"key":"826_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/CCID.S187224","volume":"12","author":"R Meza-Romero","year":"2019","unstructured":"Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019;12:373\u201381.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"826_CR23","first-page":"479","volume-title":"Comprehensive dermatologic drug therapy","author":"PB Sheth","year":"2012","unstructured":"Sheth PB, Landis MN. Topical and intralesional antiviral agents. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 3rd ed. Philadelphia: Saunders-Elsevier; 2012. p. 479.","edition":"3"},{"issue":"2","key":"826_CR24","first-page":"27","volume":"12","author":"JQ Del Rosso","year":"2019","unstructured":"Del Rosso JQ, Kircik L. Topical cantharidin in the management of molluscum contagiosum: preliminary assessment of an ether-free, pharmaceutical-grade formulation. J Clin Aesthet Dermatol. 2019;12(2):27\u201330.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"826_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jdv.16856","volume":"35","author":"S Edwards","year":"2021","unstructured":"Edwards S, Boffa MJ, Janier M, et al. 2020 European guideline on the management of genital molluscum contagiosum. J Eur Acad Dermatol Venereol. 2021;35(1):17\u201326.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"826_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076948","volume":"8","author":"CM Hughes","year":"2013","unstructured":"Hughes CM, Damon IK, Reynolds MG. Understanding US healthcare providers\u2019 practices and experiences with molluscum contagiosum. PLoS ONE. 2013;8(10): e76948.","journal-title":"PLoS ONE"},{"issue":"4","key":"826_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1525-1470.2009.00974.x","volume":"27","author":"N Al-Mutairi","year":"2010","unstructured":"Al-Mutairi N, Al-Doukhi A, Al-Farag S, Al-Haddad A. Comparative study on the efficacy, safety, and acceptability of imiquimod 5% cream versus cryotherapy for molluscum contagiosum in children. Pediatr Dermatol. 2010;27(4):388\u201394.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"826_CR28","first-page":"382","volume":"28","author":"A Qureshi","year":"2016","unstructured":"Qureshi A, Zeb M, Jalal-Ud-Din M, Sheikh ZI, Alam MA, Anwar SA. Comparison of efficacy of 10% potassium hydroxide solution versus cryotherapy in treatment of molluscum contagiosum. J Ayub Med Coll Abbottabad. 2016;28(2):382\u20135.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"6","key":"826_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s40257-018-0375-4","volume":"19","author":"PP Vakharia","year":"2018","unstructured":"Vakharia PP, Chopra R, Silverberg NB, Silverberg JI. Efficacy and safety of topical cantharidin treatment for molluscum contagiosum and warts: a systematic review. Am J Clin Dermatol. 2018;19(6):791\u2013803.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"826_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/pde.13438","volume":"35","author":"C Teixido","year":"2018","unstructured":"Teixido C, Diez O, Marsal JR, et al. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol. 2018;35(3):336\u201342.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"826_CR31","first-page":"419","volume":"66","author":"K Ogilvie-Turner","year":"2020","unstructured":"Ogilvie-Turner K, Goldman RD. Cantharidin for molluscum contagiosum. Can Fam Physician. 2020;66(6):419\u201320.","journal-title":"Can Fam Physician"},{"issue":"5","key":"826_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/pde.13228","volume":"34","author":"E Forbat","year":"2017","unstructured":"Forbat E, Al-Niaimi F, Ali FR. Molluscum contagiosum: review and update on management. Pediatr Dermatol. 2017;34(5):504\u201315.","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"826_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamadermatol.2020.3238","volume":"156","author":"LF Eichenfield","year":"2020","unstructured":"Eichenfield LF, McFalda W, Brabec B, et al. Safety and efficacy of VP-102, a proprietary, drug-device combination product containing cantharidin, 0.7% (w\/v), in children and adults with molluscum contagiosum: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156(12):1315\u201323.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"826_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/pde.12276","volume":"31","author":"VA Moye","year":"2014","unstructured":"Moye VA, Cathcart S, Morrell DS. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum. Pediatr Dermatol. 2014;31(4):450\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"826_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ijd.14079","volume":"57","author":"AK Guzman","year":"2018","unstructured":"Guzman AK, Schairer DO, Garelik JL, Cohen SR. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. Int J Dermatol. 2018;57(8):1001\u20136.","journal-title":"Int J Dermatol"},{"issue":"3","key":"826_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1067\/mjd.2000.106370","volume":"43","author":"NB Silverberg","year":"2000","unstructured":"Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43(3):503\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"826_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.36849\/JDD.5626","volume":"20","author":"S Niazi","year":"2021","unstructured":"Niazi S, Brabec B, Anschutz L, Willson C, Davidson M, Burnett P. A phase 2 open-label study to evaluate VP-102 for the treatment of molluscum contagiosum. J Drugs Dermatol. 2021;20(1):70\u20135.","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"826_CR38","first-page":"42","volume":"14","author":"LF Eichenfield","year":"2021","unstructured":"Eichenfield LF, Kwong P, Gonzalez ME, et al. Safety and efficacy of VP-102 (Cantharidin, 0.7% w\/v) in molluscum contagiosum by body region: post hoc pooled analyses from two phase III randomized trials. J Clin Aesthet Dermatol. 2021;14(10):42\u20137.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"2","key":"826_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40257-020-00570-8","volume":"22","author":"LF Eichenfield","year":"2021","unstructured":"Eichenfield LF, Siegfried E, Kwong P, et al. Pooled results of two randomized phase III trials evaluating VP-102, a drug-device combination product containing cantharidin 0.7% (w\/v) for the treatment of molluscum contagiosum. Am J Clin Dermatol. 2021;22(2):257\u201365.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"826_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100019","volume":"1","author":"T Maeda-Chubachi","year":"2021","unstructured":"Maeda-Chubachi T, Hebert D, Messersmith E, Siegfried EC. SB206, a nitric oxide-releasing topical medication, induces the beginning of the end sign and molluscum clearance. JID Inov. 2021;1(3): 100019.","journal-title":"JID Inov"},{"issue":"4","key":"826_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jaad.2019.09.064","volume":"82","author":"AA Hebert","year":"2020","unstructured":"Hebert AA, Siegfried EC, Durham T, et al. Efficacy and tolerability of an investigational nitric oxide-releasing topical gel in patients with molluscum contagiosum: a randomized clinical trial. J Am Acad Dermatol. 2020;82(4):887\u201394.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 2","key":"826_CR42","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1093\/clinids\/21.Supplement_2.S162","volume":"21","author":"MA DeGroote","year":"1995","unstructured":"DeGroote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis. 1995;21(Suppl. 2):S162\u20135.","journal-title":"Clin Infect Dis"},{"key":"826_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.niox.2008.08.002","volume":"20","author":"C Miller","year":"2009","unstructured":"Miller C, McMullin B, Ghaffari A, et al. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide. 2009;20:16\u201323.","journal-title":"Nitric Oxide"},{"key":"826_CR44","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1046\/j.1365-2672.2001.01291.x","volume":"90","author":"R Weller","year":"2001","unstructured":"Weller R, Price RJ, Ormerod AD, Benjamin N, Leifert C. Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida, and bacterial skin pathogens. J Appl Microbiol. 2001;90:648\u201352.","journal-title":"J Appl Microbiol"},{"issue":"10","key":"826_CR45","first-page":"1100","volume":"17","author":"SK Tyring","year":"2018","unstructured":"Tyring SK, Rosen T, Berman B, Stasko N, Durham T, Maeda- CT. A phase 2 controlled study of SB206, a topical nitric oxide-releasing drug for extragenital wart treatment. J Drugs Dermatol. 2018;17(10):1100\u20135.","journal-title":"J Drugs Dermatol"},{"key":"826_CR46","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1172\/JCI119473","volume":"99","author":"FC Fang","year":"1997","unstructured":"Fang FC. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818\u201325.","journal-title":"J Clin Invest"},{"issue":"4","key":"826_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/1203475420926984","volume":"24","author":"L Belmesk","year":"2020","unstructured":"Belmesk L, Litvinov IV, Netchiporouk E. SB206, a new topical nitric oxide-releasing drug on the horizon for the treatment of molluscum contagiosum and external anogenital warts. J Cutan Med Surg. 2020;24(4):412\u20133.","journal-title":"J Cutan Med Surg"},{"issue":"7","key":"826_CR48","doi-asserted-by":"publisher","first-page":"e01026-17","DOI":"10.1128\/AAC.01026-17","volume":"62","author":"N Stasko","year":"2018","unstructured":"Stasko N, McHale K, Hollenbach SJ, Martin M, Doxey R. Nitric oxide-releasing macromolecule exhibits broad-spectrum antifungal activity and utility as a topical treatment for superficial fungal infections. Antimicrob Agents Chemother. 2018;62(7):e01026-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"826_CR49","doi-asserted-by":"crossref","unstructured":"Browning JC, Enloe C, Cartwright M, et al. Efficacy and safety of topical nitric oxide-releasing berdazimer gel in patients with molluscum contagiosum: a phase 3 randomized clinical trial. JAMA Dermatol. 2022. (Epub ahead of print).","DOI":"10.1001\/jamadermatol.2022.2721"},{"key":"826_CR50","doi-asserted-by":"crossref","unstructured":"Oza VS. Molluscum contagiosum therapeutics-new options may be around the corner. JAMA Dermatol. 2022. (Epub ahead of print).","DOI":"10.1001\/jamadermatol.2022.2719"},{"issue":"7","key":"826_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15528","volume":"35","author":"G Micali","year":"2022","unstructured":"Micali G, Dall\u2019Oglio F, Verz\u00ec AE, Platania H, Lacarrubba F. Home treatment of single cutaneous warts combining face-to-face and teledermatology consultation: a new perspective. Dermatol Ther. 2022;35(7): e15528.","journal-title":"Dermatol Ther"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00826-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T21:18:56Z","timestamp":1668892736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00826-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00826-7","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}